BMX-001 as a therapeutic agent for treatment of high-grade gliomas

Ended Project Grant Awarded Last action

Award ID
R44CA195749
Recipient
Awarding agency
Obligated
$10,003,252

Award facts

Assistance listing
93.395 Cancer Treatment Research
Completion date
Originally
Funding
  • $8,003,252.00 Federal
  • $2,000,000.00 Non-federal
Place of performance
Greenwood Village, CO 80111, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $1,625 $0
Amendment BMX-001 as a therapeutic agent for treatment of high-grade gliomas - description (provided by applicant): phase 1 and phase 2 clinical trials of a new class… $1,625 $0
Amendment $2,000,000 $0
Amendment $2,000,000 $2,000,000
Amendment $0 $0
Amendment $2,000,000 $0
Amendment $0 $0
Amendment $0 $0
Amendment $1,023,555 $0
Original award $976,447 $0
Show all 11

Quick answers

Who received award R44CA195749?

R44CA195749 was awarded to Biomimetix JV, LLC by National Cancer Institute (National Institutes of Health) on September 18, 2015.

How much is award R44CA195749 worth?

$10,003,252 has been obligated on R44CA195749: $8,003,252 in federal funding and $2,000,000 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award